Aptose Biosciences Inc
Officers & Directors
Warren Whitehead Director Mark D. Vincent, M.D. Director Fletcher Payne Senior Vice President and Chief Financial Officer (Principal Financial Officer and Accounting Officer) Denis R. Burger, Ph.D. Director, Lead Independent Erich M. Platzer, M.D., Ph.D. Director Chartered Professional Accountants, Licensed Public Accountants, Vaughan, Canada Bernd R. Seizinger, M.D., Ph.D. Director Carol G. Ashe Director William G. Rice, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) ,
Aptose Biosciences Inc currently has 14 employees.
News about Aptose Biosciences Inc Key Personnel |
In recent news, Aptose Biosciences Inc, a leading biopharmaceutical company, has announced a registered direct offering priced at-the-market under Nasdaq rules, raising $4.43 million. This development comes amidst a decline in share prices, which plummeted by -30.63% during the second quarter of 2024. Furthermore, the company recorded a significant net loss of $49 million in the twelve-month period ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -221.97%. Despite these challenges, Aptose Biosciences Inc has showcased progress in the healthcare sector, improving its overall ROI ranking.
The registered direct offering marks an important financial mo...
|
|
